HIV Outcomes Beyond Viral Suppression
In the era of modern antiretroviral therapy people living with HIV can expect to live a normal lifespan. However substantial barriers to accessing non-HIV related care exist and impact the wellbeing of this population.
Current targets for the HIV response focus on testing, treatment and viral suppression. This new Series, published by The Lancet HIV, and the first for the journal, explores wider aims, beyond viral suppression, and argues for an additional measure focusing on health-related quality of life. The role patient-reported outcomes could play in measuring progress and how stigma undermines health-related quality of life are also examined. The Series consists of 3 papers and has 2 linked Commentaries. There will also be an accompanying Editorial from The Lancet HIV.
The findings of the Series are due to be presented at “Delivering on political commitments to tackle HIV in Europe”, an event at the European Parliament, Strasbourg, France, on Monday November 26.